US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist

7.500
0.0000.00%

Close Nov 29 13:00 ET

7.430
-0.070-0.93%

Post 17:01 ET

1.55BMarket Cap-12295P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

141.44%8.25M

92.73%-1.37M

-12.99%-53.68M

41.22%-95.14M

62.61%-8.92M

38.67%-19.9M

32.22%-18.81M

38.93%-47.51M

-13.85%-161.85M

26.53%-23.85M

Net income from continuing operations

61.18%-14.03M

83.17%-12.67M

33.66%-35.38M

8.33%-226.54M

13.71%-61.73M

14.98%-36.15M

-27.98%-75.33M

28.12%-53.33M

-34.26%-247.12M

-302.39%-71.54M

Operating gains losses

----

--29.02M

--0

----

Depreciation and amortization

-25.95%311K

-21.38%320K

-24.44%306K

15.17%1.66M

6.82%423K

7.97%420K

21.49%407K

27.76%405K

84.94%1.44M

131.58%396K

Other non cash items

-34.30%14.53M

-17.36%19.6M

-4.95%19.44M

-13.65%86.23M

-55.42%19.94M

20.22%22.11M

33.85%23.72M

7.63%20.45M

84.21%99.85M

151.81%44.73M

Change In working capital

43.62%-9.13M

-175.38%-18.3M

-75.44%-48.52M

45.03%-32.4M

253.94%18.1M

9.64%-16.2M

-301.58%-6.64M

15.04%-27.66M

-825.57%-58.95M

-179.66%-11.76M

-Change in receivables

-186.31%-3.32M

8.25%-8.25M

-290.14%-3.84M

71.61%-6.1M

61.14%-2.97M

358.96%3.84M

-69.73%-8.99M

128.65%2.02M

-3.14%-21.47M

-136.04%-7.64M

-Change in inventory

55.11%-1.52M

-17.71%739K

-1,031.30%-1.22M

88.33%-1.45M

178.19%907K

7.84%-3.39M

112.41%898K

137.01%131K

-41.70%-12.42M

45.72%-1.16M

-Change in prepaid assets

75.75%-1.47M

64.16%1.75M

143.42%1.11M

-164.03%-6.82M

148.93%710K

-7,273.17%-6.05M

-16.30%1.06M

-9.78%-2.55M

63.90%-2.58M

60.73%-1.45M

-Change in payables and accrued expense

69.45%-2.83M

-6,567.02%-12.53M

-63.70%-44.57M

24.84%-16.81M

1,964.17%19.87M

27.80%-9.26M

-101.30%-188K

-18.85%-27.23M

-151.31%-22.36M

-104.63%-1.07M

-Change in other working capital

----

-1,028.44%-1.23M

4.34%-419K

-1,041.26%-1.35M

413.51%570K

-146.67%-35K

-108.50%-109K

-153.03%-438K

Cash from discontinued investing activities

Operating cash flow

141.44%8.25M

92.73%-1.37M

-12.99%-53.68M

41.22%-95.14M

62.61%-8.92M

38.67%-19.9M

32.22%-18.81M

38.93%-47.51M

-13.85%-161.85M

26.53%-23.85M

Investing cash flow

Cash flow from continuing investing activities

-63.28%8.49M

87.13%-2.45M

126.85%28.76M

-2.54%-131.5M

-136.87%-28.47M

133.24%23.12M

80.46%-19.04M

-178.41%-107.11M

-911.43%-128.24M

794.38%77.22M

Net PPE purchase and sale

94.02%-59K

66.81%-155K

-46.88%-235K

-60.47%-2.17M

-5.32%-554K

-464.00%-987K

-91.39%-467K

60.59%-160K

43.35%-1.35M

52.53%-526K

Net investment purchase and sale

-64.54%8.55M

87.65%-2.29M

127.11%28.99M

-1.93%-129.33M

-135.91%-27.92M

134.75%24.11M

80.90%-18.57M

-180.96%-106.95M

-797.60%-126.89M

876.48%77.74M

Cash from discontinued investing activities

Investing cash flow

-63.28%8.49M

87.13%-2.45M

126.85%28.76M

-2.54%-131.5M

-136.87%-28.47M

133.24%23.12M

80.46%-19.04M

-178.41%-107.11M

-911.43%-128.24M

794.38%77.22M

Financing cash flow

Cash flow from continuing financing activities

4.00%1.27M

-106.70%-1.97M

-120.64%-1.05M

-63.10%32.49M

-175.57%-3.17M

-98.40%1.23M

19,870.07%29.36M

-30.98%5.08M

-75.53%88.03M

-98.79%4.2M

Net issuance payments of debt

---556K

-100.68%-402K

---390K

-20.10%58.38M

---1.17M

--0

--59.55M

--0

-75.13%73.07M

--0

Net common stock issuance

-45.45%6K

-94.17%12K

--11K

80.00%342K

--125K

--11K

--206K

--0

-99.62%190K

----

Proceeds from stock option exercised by employees

41.26%2.09M

-84.90%264K

-66.89%1.68M

-43.52%8.34M

-99.03%39K

-54.63%1.48M

1,089.12%1.75M

-30.98%5.08M

-6.16%14.77M

15.07%4.01M

Net other financing activities

0.38%-261K

---1.84M

---2.35M

---34.58M

---2.17M

---262K

----

Cash from discontinued financing activities

Financing cash flow

4.00%1.27M

-106.70%-1.97M

-120.64%-1.05M

-63.10%32.49M

-175.57%-3.17M

-98.40%1.23M

19,870.07%29.36M

-30.98%5.08M

-75.53%88.03M

-98.79%4.2M

Net cash flow

Beginning cash position

-45.73%80.21M

-45.00%86.13M

-63.28%112.45M

-39.69%306.24M

-38.60%152.49M

-46.07%147.79M

-60.74%156.6M

-39.69%306.24M

85.07%507.73M

21.80%248.34M

Current changes in cash

304.95%18.01M

31.91%-5.78M

82.63%-25.98M

3.91%-194.15M

-170.47%-40.56M

117.33%4.45M

93.21%-8.49M

-37.30%-149.54M

-186.60%-202.06M

-81.05%57.57M

Effect of exchange rate changes

236.36%851K

54.89%-143K

-254.17%-340K

-36.04%362K

57.70%522K

1,907.14%253K

-251.67%-317K

-340.00%-96K

697.18%566K

16,450.00%331K

End cash Position

-35.04%99.06M

-45.73%80.21M

-45.00%86.13M

-63.28%112.45M

-38.60%152.49M

-46.07%147.79M

-60.74%156.6M

-39.69%306.24M

Free cash flow

139.20%8.19M

92.10%-1.52M

-13.10%-53.92M

40.37%-97.31M

61.14%-9.47M

35.98%-20.88M

31.14%-19.28M

39.04%-47.67M

-12.91%-163.2M

27.38%-24.38M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	141.44%8.25M	92.73%-1.37M	-12.99%-53.68M	41.22%-95.14M	62.61%-8.92M	38.67%-19.9M	32.22%-18.81M	38.93%-47.51M	-13.85%-161.85M	26.53%-23.85M
Net income from continuing operations	61.18%-14.03M	83.17%-12.67M	33.66%-35.38M	8.33%-226.54M	13.71%-61.73M	14.98%-36.15M	-27.98%-75.33M	28.12%-53.33M	-34.26%-247.12M	-302.39%-71.54M
Operating gains losses	----	----	----	--29.02M	--0	--0	----	----	----	----
Depreciation and amortization	-25.95%311K	-21.38%320K	-24.44%306K	15.17%1.66M	6.82%423K	7.97%420K	21.49%407K	27.76%405K	84.94%1.44M	131.58%396K
Other non cash items	-34.30%14.53M	-17.36%19.6M	-4.95%19.44M	-13.65%86.23M	-55.42%19.94M	20.22%22.11M	33.85%23.72M	7.63%20.45M	84.21%99.85M	151.81%44.73M
Change In working capital	43.62%-9.13M	-175.38%-18.3M	-75.44%-48.52M	45.03%-32.4M	253.94%18.1M	9.64%-16.2M	-301.58%-6.64M	15.04%-27.66M	-825.57%-58.95M	-179.66%-11.76M
-Change in receivables	-186.31%-3.32M	8.25%-8.25M	-290.14%-3.84M	71.61%-6.1M	61.14%-2.97M	358.96%3.84M	-69.73%-8.99M	128.65%2.02M	-3.14%-21.47M	-136.04%-7.64M
-Change in inventory	55.11%-1.52M	-17.71%739K	-1,031.30%-1.22M	88.33%-1.45M	178.19%907K	7.84%-3.39M	112.41%898K	137.01%131K	-41.70%-12.42M	45.72%-1.16M
-Change in prepaid assets	75.75%-1.47M	64.16%1.75M	143.42%1.11M	-164.03%-6.82M	148.93%710K	-7,273.17%-6.05M	-16.30%1.06M	-9.78%-2.55M	63.90%-2.58M	60.73%-1.45M
-Change in payables and accrued expense	69.45%-2.83M	-6,567.02%-12.53M	-63.70%-44.57M	24.84%-16.81M	1,964.17%19.87M	27.80%-9.26M	-101.30%-188K	-18.85%-27.23M	-151.31%-22.36M	-104.63%-1.07M
-Change in other working capital	----	----	----	-1,028.44%-1.23M	4.34%-419K	-1,041.26%-1.35M	413.51%570K	-146.67%-35K	-108.50%-109K	-153.03%-438K
Cash from discontinued investing activities
Operating cash flow	141.44%8.25M	92.73%-1.37M	-12.99%-53.68M	41.22%-95.14M	62.61%-8.92M	38.67%-19.9M	32.22%-18.81M	38.93%-47.51M	-13.85%-161.85M	26.53%-23.85M
Investing cash flow
Cash flow from continuing investing activities	-63.28%8.49M	87.13%-2.45M	126.85%28.76M	-2.54%-131.5M	-136.87%-28.47M	133.24%23.12M	80.46%-19.04M	-178.41%-107.11M	-911.43%-128.24M	794.38%77.22M
Net PPE purchase and sale	94.02%-59K	66.81%-155K	-46.88%-235K	-60.47%-2.17M	-5.32%-554K	-464.00%-987K	-91.39%-467K	60.59%-160K	43.35%-1.35M	52.53%-526K
Net investment purchase and sale	-64.54%8.55M	87.65%-2.29M	127.11%28.99M	-1.93%-129.33M	-135.91%-27.92M	134.75%24.11M	80.90%-18.57M	-180.96%-106.95M	-797.60%-126.89M	876.48%77.74M
Cash from discontinued investing activities
Investing cash flow	-63.28%8.49M	87.13%-2.45M	126.85%28.76M	-2.54%-131.5M	-136.87%-28.47M	133.24%23.12M	80.46%-19.04M	-178.41%-107.11M	-911.43%-128.24M	794.38%77.22M
Financing cash flow
Cash flow from continuing financing activities	4.00%1.27M	-106.70%-1.97M	-120.64%-1.05M	-63.10%32.49M	-175.57%-3.17M	-98.40%1.23M	19,870.07%29.36M	-30.98%5.08M	-75.53%88.03M	-98.79%4.2M
Net issuance payments of debt	---556K	-100.68%-402K	---390K	-20.10%58.38M	---1.17M	--0	--59.55M	--0	-75.13%73.07M	--0
Net common stock issuance	-45.45%6K	-94.17%12K	--11K	80.00%342K	--125K	--11K	--206K	--0	-99.62%190K	----
Proceeds from stock option exercised by employees	41.26%2.09M	-84.90%264K	-66.89%1.68M	-43.52%8.34M	-99.03%39K	-54.63%1.48M	1,089.12%1.75M	-30.98%5.08M	-6.16%14.77M	15.07%4.01M
Net other financing activities	0.38%-261K	---1.84M	---2.35M	---34.58M	---2.17M	---262K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	4.00%1.27M	-106.70%-1.97M	-120.64%-1.05M	-63.10%32.49M	-175.57%-3.17M	-98.40%1.23M	19,870.07%29.36M	-30.98%5.08M	-75.53%88.03M	-98.79%4.2M
Net cash flow
Beginning cash position	-45.73%80.21M	-45.00%86.13M	-63.28%112.45M	-39.69%306.24M	-38.60%152.49M	-46.07%147.79M	-60.74%156.6M	-39.69%306.24M	85.07%507.73M	21.80%248.34M
Current changes in cash	304.95%18.01M	31.91%-5.78M	82.63%-25.98M	3.91%-194.15M	-170.47%-40.56M	117.33%4.45M	93.21%-8.49M	-37.30%-149.54M	-186.60%-202.06M	-81.05%57.57M
Effect of exchange rate changes	236.36%851K	54.89%-143K	-254.17%-340K	-36.04%362K	57.70%522K	1,907.14%253K	-251.67%-317K	-340.00%-96K	697.18%566K	16,450.00%331K
End cash Position	-35.04%99.06M	-45.73%80.21M	-45.00%86.13M	-63.28%112.45M	-63.28%112.45M	-38.60%152.49M	-46.07%147.79M	-60.74%156.6M	-39.69%306.24M	-39.69%306.24M
Free cash flow	139.20%8.19M	92.10%-1.52M	-13.10%-53.92M	40.37%-97.31M	61.14%-9.47M	35.98%-20.88M	31.14%-19.28M	39.04%-47.67M	-12.91%-163.2M	27.38%-24.38M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data